Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain

NCT: NCT03625752 · ACTIVE_NOT_RECRUITING

NCT IDNCT03625752
StatusACTIVE_NOT_RECRUITING
Start Date2019-06-06
Completion2027-05-07
SponsorCase Western Reserve University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the effects of Transcranial Direct Current Stimulation (tDCS) in combination with Transcranial ultrasound (TUS) for the treatment of pain and functional limitations in subjects with Diabetic Neuropathic Pain.

Frequently Asked Questions

What is Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain?

Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain is a clinical trial registered under NCT03625752. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03625752?

The current status of NCT03625752 (Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain) is: ACTIVE_NOT_RECRUITING.

When did Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain start?

Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain started on 2019-06-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑